Microsoft word - ccb mar learning program overview

CCB Science 2 Service Learning Series According to the Federal Government and SAMHSA:
Medication Assisted Recovery
Medication-Assisted Treatment (MAT) is a form of pharmacotherapyand refers to any treatment for a substance use disorder that includes a Learning Program
pharmacologic intervention as part of a comprehensive substance abusetreatment plan with an ultimate goal of patient recovery with full socialfunction.
Medication Assisted Treatment (MAT) of
In the US, MAT has been demonstrated to be effective in the treatmentof alcohol dependence with Food and Drug Administration approved substance use disorders presents a unique clinical chal enge drugs such as disulfiram, naltrexone and acamprosate; and opioid that requires MAT-specific skil s and training. As new dependence with methadone, naltrexone and buprenorphine.
medications become available and more individuals considerpharmacotherapy treatment options, it wil be increasingly As part of a comprehensive treatment program, MAT has been shown to: important to have behavioral health professionals skil ed and knowledgeable of MAT treatment options, clinical chal enges and the recovery support needs for this unique group of • Decrease hepatitis and HIV seroconversion• Decrease criminal activities • Increase employment• Improve birth outcomes with perinatal addicts To help increase awareness of MAT treatment options andto support the dissemination of accurate, research & Medications for Alcohol Dependence
science-based information, the CCB has developed a comprehensive learning program based upon the most recent trends in the field of pharmacotherapy of opioid andalcohol dependence. The program is designed to provide a Medications for Opioid Dependence
comprehensive overview of the basic pharmacology, recovery supports, clinical and practice issues related to the treatment of addictive disorders using pharmacotherapy aspart of a comprehensive recovery plan that includes clinical Content from SAMSHA website – Division of Pharmacotherapy services, recovery supports and other essential aspects of for more info, please visit this important emerging area of addiction recovery.
Workshop I: Introduction to Medication Assisted Recovery
Workshop III: Integrating Recovery Supports into Medication
Presented by Marshal Rosier This workshop presents an overview
Assisted Treatment
of the science of addiction and several emerging trends in the field of Presented by Marshal Rosier This workshop presents an overview of the
addiction treatment and recovery. The concept of medication assisted stages of change, motivational interviewing and motivational enhancement recovery is discussed identifying several key principles for practitioners to strategies when working with people in recovery. Participants are given information consider when working with people in recovery. The stigma of addiction and about how to use motivational strategies to support recovery and tools to assist the bias against MAT is addressed as well as other barriers to recovery. them in providing basic education on MAT to clients, family members and Final y, the workshops presents a brief overview of the three medications community stakeholders. The workshop also introduces the recovery supports and approved for the treatment of opioid dependence: methadone, explains the importance of factoring recovery support needs when developing buprenorphine and naltrexone as well as the three medications approved for recovery plan for people on MAT. Several resources are provided to participants the treatment of alcohol dependence: naltrexone, disulfiram, and including web-based resources, educational and recovery support services. Workshop IV: Medication Assisted Recovery: Collaboration,
Workshop II: Current Trends in Medication Assisted
Integration and Ethical Issues
Presented by Marshal Rosier & Dr. Pat Mulready This workshop
Presented by Dr. Pat Mulready This workshop begins with an
focuses on strategies to increase col aboration between behavioral health overview of the neuroanatomy of the brain and how neurotransmitters professionals and medical/community providers that may share clients being served operate within the brain normal y and how those structures and chemicals by MAT. The workshop includes a discussion of common comorbid medical issues to are affected by exposure to drugs and alcohol. Focusing on the medication consider when referring people to MAT services as well as determining used to treatment addiction, the workshops reviews medications used to appropriateness for treatment and treatment options. Ethical issues related to MAT treat opioid, alcohol and nicotine use disorders as well as other emerging and common ethical dilemmas in MAT settings are considered as well as the pharmacotherapy treatment options. importance of professional competence of clinicians providing MATS services. For more info about the CCB Medication Assisted Recovery Program or the MATS credential, visit or call 203.284.8800
CCB Announces New Medication
Medication Assisted Recovery Distance Learning Program
Assisted Treatment Specialist Credential
The CCB Science 2 Service MAR DL Program is a self-paced learning program that isdeveloped using science-based materials within the public domain such as TIPs, TAPs,research reports and training manuals. The DL Program al ows participants to earn Wal ingford, CT – In March 2009, the CCB developed the MATS credential CCB approved training hours that can be applied toward initial certification or which is intended for practitioners providing counseling, recovery supports, recertification while reading high quality science-based content.
case management, medical treatment or other services to people inrecovery that are benefiting from Medication Assisted treatments (MAT) The CCB Science 2 Service MAR DL Program has 17 modules based upon the fol owing such as methadone, buprenorphine/suboxone, naltrexone, acamprosate, disulfram, chantix and other medications used in the treatment of addictivedisorders. One of the primary purposes of this board specialty is to identify TIP 43: Medication Assisted Treatment for Opioid Addiction in Opioid
practitioners with a special interest in or commitment to medication Treatment Programs (SAMHSA/CSAT, 2005) Treatment
assisted treatment and recovery and have chosen to demonstrate their Imporvement Protocol (TIP) Series 43. DHHS Publication basic competency in the knowledge and skil s of a Medication Assisted Treatment Specialist as identified in the CCB Medication Assisted
TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment
Treatment Specialist Job Task Analysis (2008).
of Opioid Addiction. (SAMHSA/CSAT, 2004) Treatment Improvement
Protocol(TIP) Series 40. DHHS Publication No. (SMA)04-3939.
Medication assisted treatment (MAT) of substance use disorders presents a Mid America ATTC: Psychotherapeutic Medications 2008: What Every
unique clinical chal enge that requires MAT-specific skil s and training. The Counselor Should Know.
MAT Specialist credential wil be available for those interested in completing45 hours of MAT-specific training and successful y passing the CCB MATS TIP 35: Enhancing Motivation for Change in Substance Abuse Treatment.
written exam. The credential wil not require that a practitioner be licensed (SAMHSA/CSAT, 1999) Treatment Improvement Protocol (TIP) Series or certified in a behavioral health or medical field (although this is strongly encouraged and wil be the primary intended audience), so that people inrecovery, MAT advocates, policy makers, behavioral health professionals,medical and pharmaceutical professionals, family members, and others thathave a special interest in MAT can obtain the credential.
Medication Assisted Treatment Specialist (MATS)
Certification Requirements
MATS certification is one way to demonstrate that you have met establishedstandards of MAT competency and capability. MATS certification through I. Training Requirements - 45 hours of MAT Specific
the CCB, however, does not al ow an individual any practice permission orscope of practice that is not provided by their agency, license, educational training with domain requirements:
training or professional scope under other credentials/licenses. MATS Etiology & Medication Assisted Treatment
certification with the CCB does not al ow an individual to practice as a Addiction Pharmacotherapy
private practice clinician and does not determine eligibility or provide Recovery Supports & MAT
permission to practice without meeting other requirements as determined Collaborating with MAT & Medical Providers
by the Connecticut Department of Public Health. For questions about MAT Specific Ethics
practice requirements, scope of practice or licensure requirements ofprivate practice clinicians, please contact the Connecticut Department of II. MATS Written Exam
Public Health at
A passing score on the CCB MATS written exam is required for al applicants
after September 2009

The Connecticut Certification Board’s process for credentialing MATSpractitioners currently requires meeting established standards in MAT-specific training and obtaining a passing score on the CCB MATS written III. Licensure or Certification
exam. Ongoing professional development and adherence to the CCB Although MATS certification is primarily intended for certified and licensed
Medication Assisted Treatment Specialist Code of Ethics are also required of behavioral health professionals (i.e., Addiction Counselors, Mental Health
the MATS credential. This credential is currently not a reciprocal credential
Clinicians, Social Workers, Nurses, Physicians, Administrators), no certification
and not transferable through the IC&RC to other IC&RC member regions.
or license is currently required.
Medication Assisted Treatment Specialist (MATS)
Medication Assisted Treatment Specialist (MATS)
Performance Domains
Written Exam
I. Pharmacotherapy
II. Recovery Supports
Recovery Supports
III. Education
IV. Professional Responsibility
Professional Responsibility
For more information about the MATS Job Task Analysis (2008), please visit The MATS exam is a 1 hour and 15 minute 50 item multiple choice exam administered by the CCB. The cost of the exam is $50.00 and wil be required of al MATS applicantsafter September 2009.


Liste et utilisation des médicaments de la mallette d’urgence pour les patients en soins palliatifs (par ordre alphabétique)§ Buscopan® (Scopolamine butylbromide) ampoule 20 mg Indication : douleur spasmodique, iléus Voie d’administration : sc, im, iv, peut être administré en iv direct, compatible avec du NaCl 0.9% Posologie habituelle : 20 mg 3-4x/j, maximum 120 mg/j

Forum abstract

“Il futuro è aperto biologicamente e spiritualmente” “The future is biologically and spiritually open” Karl Popper, Konrad Lorenz “L’insegnamento della medicina. Il programma universitarioper il medico del futuro: l’omeopata”“Teaching Medicine. The University programmefor the future medical doctor: the homeopath”Sorrento Palace Hotel – February 24-27 -2000Sorrento, Ita

Copyright © 2010-2014 Internet pdf articles